Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -C$23.85M. The highest annual figure on record is -C$9.13M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -C$23.85M | – |
| FY2024 | Dec 31, 2024 | -C$25.06M | – |
| FY2023 | Dec 31, 2023 | -C$25.18M | – |
| FY2022 | Dec 31, 2022 | -C$27.22M | – |
| FY2021 | Dec 31, 2021 | -C$23.54M | – |
| FY2020 | Dec 31, 2020 | -C$9.13M | – |
See a number that looks wrong?